Current Views on the Clinical Relevance of Blastocystis spp.
Blastocystis is an enteric protistan parasite of uncertain clinical relevance. Recent studies indicate that the parasite is a species complex and humans are potentially hosts to nine Blastocystis subtypes, most of which are zoonotic. Subtype 3 is the most common in prevalence studies, followed by subtype 1. Laboratory diagnosis is challenging; the currently recommended diagnostic approach is trichrome staining of direct smears coupled with stool culture. Polymerase chain reaction testing from stools or culture is useful for determining Blastocystis subtype information. The controversial pathogenesis of Blastocystis is attributed to subtype variations in virulence; although current studies seem to support this idea, evidence suggests other factors also contribute to the clinical outcome of the infection. Clinical signs and symptoms of blastocystosis include abdominal pain, diarrhea, bloating, and flatulence. Extraintestinal manifestations, predominantly cutaneous, also were reported. In vitro and animal studies shed new light on the pathobiology of Blastocystis.
KeywordsBlastocystis Pathogenesis Subtypes Diagnosis Prevalence
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008;21:639–65. This article is an authoritative and comprehensive review of recent advances in Blastocystis biology with a focus on clinical and diagnostic aspects.CrossRefPubMedGoogle Scholar
- 6.• Stensvold CR, Suresh GK, Tan KS, et al. Terminology for Blastocystis subtypes—a consensus. Trends Parasitol 2007;23:93–6. This article describes a timely proposal aimed at reconciling discrepant terminologies of various Blastocystis genotypes. It proposes that all mammalian and avian isolates are designated Blastocystis sp and assigned to a subtype from 1 to 9.CrossRefPubMedGoogle Scholar
- 12.• Stensvold CR, Traub RJ, von Samson-Himmelstjerna G, et al. Detecting Blastocystis by parasitological and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis 2007;59:303–7. This article provides a comprehensive comparison of major laboratory diagnostic approaches used in the identification of Blastocystis. Culture and PCR were shown to be superior whereas the formol ethyl acetate concentration technique lacked sensitivity.PubMedGoogle Scholar
- 19.• Utzinger J, Botero-Kleiven S, Castelli F, et al. Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories. Clin Microbiol Infect 2009, Epub ahead of print. This article describes a study comparing the diagnostic performance of different European reference laboratories in diagnosing helminthes and intestinal protozoa. The laboratories fared the worst in identifying Blastocystis.Google Scholar
- 24.• Stensvold CR, Alfellani MA, Nørskov-Lauritsen S, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol 2009;39:473–9. This article comprehensively surveys Blastocystis subtypes in numerous animal hosts.CrossRefPubMedGoogle Scholar
- 34.Londoño AL, Mejía S, Gómez-Martin JE. Prevalence and risk factors associated with intestinal parasitism in preschool children from urban area of Calarcá, Colombia [in Spanish]. Rev Salud Publica (Bogota) 2009;11:72–81.Google Scholar
- 39.• Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 2008;102:853–60. This article describes a well-conducted study showing subtype-dependent pathology in a rat model.CrossRefPubMedGoogle Scholar
- 41.• Puthia MK, Sio SW, Lu J, Tan KS. Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement and barrier function disruption in IEC-6 cells. Infect Immun 2006;74:4114–23. This article provides a detailed characterization of Blastocystis cytopathic effects using an in vitro model system.CrossRefPubMedGoogle Scholar
- 45.Wu B, Yin J, Texier C, Roussel M, Tan KS. Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme. J Biol Chem 2010;285:1790–8.Google Scholar
- 50.• Stensvold CR, Smith HV, Nagel R, et al. Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 2009, Epub ahead of print. This timely review discusses the complexities of Blastocystis chemotherapy.Google Scholar